Logo image of ACHL

ACHILLES THERAPEUTICS PL-ADR (ACHL) Stock Analyst Ratings

NASDAQ:ACHL - Nasdaq - US00449L1026 - ADR - Currency: USD

1.39  0 (0%)

After market: 1.38 -0.01 (-0.72%)

Buy % Consensus

40

ChartMill assigns a Buy % Consensus number of 40% to ACHL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.12. This target is 340.29% above the current price.
ACHL was analyzed by 6 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ACHL.
In the previous month the buy percentage consensus was at a similar level.
ACHL was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

ACHL Historical Analyst RatingsACHL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -46 -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.396.066.126.126.30 - 335.97% 340.29% 340.29% 353.24%

Related screens

ACHL Current Analyst RatingACHL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5
Up and Down Grades
Date Firm Action Rating
2024-04-05 Chardan Capital Maintains Buy -> Buy
2024-04-05 Piper Sandler Downgrade Overweight -> Neutral
2023-12-14 B of A Securities Downgrade Buy -> Underperform
2023-08-07 Chardan Capital Reiterate Buy -> Buy
2023-05-11 Chardan Capital Maintains Buy -> Buy
2022-12-07 Chardan Capital Maintains Buy
2022-12-07 Piper Sandler Maintains Overweight
2021-04-26 Chardan Capital Initiate Buy
2021-04-26 Oppenheimer Initiate Outperform
2021-04-26 JP Morgan Initiate Underweight
2021-04-26 B of A Securities Initiate Buy
2021-04-26 Piper Sandler Initiate Overweight